<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="brief-report"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Res Notes</journal-id><journal-id journal-id-type="iso-abbrev">BMC Res Notes</journal-id><journal-title-group><journal-title>BMC Research Notes</journal-title></journal-title-group><issn pub-type="epub">1756-0500</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8186047</article-id><article-id pub-id-type="publisher-id">5644</article-id><article-id pub-id-type="doi">10.1186/s13104-021-05644-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Note</subject></subj-group></article-categories><title-group><article-title><italic>Exiguobacterium</italic> sp. is endowed with antibiotic properties against Gram positive and negative bacteria</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cavanaugh</surname><given-names>Nicole T.</given-names></name><address><email>cavanaugh.n@northeastern.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Parthasarathy</surname><given-names>Anutthaman</given-names></name><address><email>axpsbi@rit.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Wong</surname><given-names>Narayan H.</given-names></name><address><email>narayan.wong@chromamedicine.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Steiner</surname><given-names>KayLee K.</given-names></name><address><email>kaylee.k.steiner@vanderbilt.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Chu</surname><given-names>Jonathan</given-names></name><address><email>jxc9163@rit.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Adjei</surname><given-names>Joseph</given-names></name><address><email>joa9194@g.rit.edu</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5690-4322</contrib-id><name><surname>Hudson</surname><given-names>Andr&#x000e9; O.</given-names></name><address><email>aohsbi@rit.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.262613.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2323 3518</institution-id><institution>Thomas H. Gosnell School of Life Sciences, </institution><institution>Rochester Institute of Technology, </institution></institution-wrap>85 Lomb Memorial Drive, Rochester, NY 14623 USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.262613.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2323 3518</institution-id><institution>National Technical Institute for the Deaf, Rochester Institute of Technology, </institution></institution-wrap>52 Lomb Memorial Drive, Rochester, NY 14623 USA </aff></contrib-group><pub-date pub-type="epub"><day>8</day><month>6</month><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>8</day><month>6</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>14</volume><elocation-id>230</elocation-id><history><date date-type="received"><day>30</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>2</day><month>6</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2021</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract id="Abs1"><sec><title>Objective</title><p id="Par1">In order to isolate and identify bacteria that produce potentially novel bactericidal/bacteriostatic compounds, two ponds on the campus of the Rochester Institute of Technology (RIT) were targeted as part of a bioprospecting effort.</p></sec><sec><title>Results</title><p id="Par2">One of the unique isolates, RIT 452 was identified as <italic>Exiguobacterium</italic> sp. and subjected to whole-genome sequencing. The genome was assembled and in silico analysis was performed to predict the secondary metabolite gene clusters, which suggested the potential of <italic>Exiguobacterium</italic> RIT452 for producing antibiotic compounds. Extracts of spent growth media of RIT452 were active in disc diffusion assays performed against four reference strains, two Gram-negative (<italic>E. coli</italic> ATCC 25922 and <italic>P. aeruginosa</italic> ATCC 27853) and two Gram-positive (<italic>B. subtilis</italic> BGSC 168 and <italic>S. aureus</italic> ATCC 25923). Differential extraction and liquid chromatography was used to fractionate the extracts. Efforts to identify and elucidate the structure of the active compound(s) are still ongoing.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s13104-021-05644-2.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Antibiotic resistance</kwd><kwd><italic>Exiguobacterium</italic></kwd><kwd>Whole-genome sequencing</kwd><kwd>Secondary metabolite</kwd><kwd>Antibiotics</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>RG15GM120653</award-id><principal-award-recipient><name><surname>Hudson</surname><given-names>Andr&#x000e9; O.</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2021</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par20">Antibiotic resistance was first discovered in the 1940s, when it was observed that bacteria were become increasingly resistant to measures taken against them [<xref ref-type="bibr" rid="CR1">1</xref>]. However, this development did not become a global issue until antibiotic abuse in medicine and animal husbandry became more widespread [<xref ref-type="bibr" rid="CR2">2</xref>&#x02013;<xref ref-type="bibr" rid="CR4">4</xref>]. Antibiotic resistance dramatically increased in the 1980s and 1990s due to a discovery void. The progressive increase of antibiotic resistance and the decline in research and development of antibiotics combined to produce the current crisis [<xref ref-type="bibr" rid="CR5">5</xref>]. Since there have been few developments in the creation of new antibiotic classes for many years, bacteria are becoming increasingly resistant to those that are currently in use [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. The targets of antibiotics are diverse; protein synthesis, DNA replication, RNA synthesis and the cell membrane are common targets [<xref ref-type="bibr" rid="CR4">4</xref>]. Antibiotics with novel targets need to be developed for replacing the existing drugs.</p><p id="Par21">The &#x003b2;-lactam core structure is part of a number of antibiotic classes, but &#x003b2;-lactam resistance is widespread and is conferred by over 300 types of &#x003b2;-lactamases, of which 200 are able to hydrolyze extended spectrum cephalosporin antibiotics [<xref ref-type="bibr" rid="CR7">7</xref>]. Therefore, increasing the structural diversity of antimicrobial compounds becomes important. Estimates of all possible small molecules are pegged at 10<sup>63</sup> distinct molecules, of which many may not be accessible by synthesis [<xref ref-type="bibr" rid="CR8">8</xref>]. Only a small fraction of these molecules are biologically relevant [<xref ref-type="bibr" rid="CR9">9</xref>]. However, natural compounds offer better chances of finding bioactive molecules with entirely new chemical scaffolds than combinatorial chemistry libraries, since they have evolved to be bioactive, and can often enter cells via transmembrane transporters rather than by passive diffusion [<xref ref-type="bibr" rid="CR10">10</xref>]. Statistical analysis reveals the continuing trend of chemical novelty in natural products as de-replication tools are increasingly being implemented [<xref ref-type="bibr" rid="CR11">11</xref>]. In this context, shifting to less known bacterial phyla, rather than over-represented phyla such as the Actinobacteria might increase diversity of the antibiotics identified by prospecting [<xref ref-type="bibr" rid="CR12">12</xref>]. The goal of our study is to identify novel bacteria that yield potentially novel compounds, which may become starting points to develop more specific and potent antibiotics.</p><p id="Par22">RIT452 was identified during the screening of bacterial isolates from a campus pond, with potential bacteriostatic/bactericidal properties, and its genome was sequenced. The genome was subjected to secondary metabolite analysis via the antibiotics and secondary metabolite analysis shell 5.0 (antiSMASH) [<xref ref-type="bibr" rid="CR13">13</xref>] and the antibiotic resistance target seeker (ARTS) platforms [<xref ref-type="bibr" rid="CR14">14</xref>]. Organic compounds extracted from the spent growth media of RIT452 were shown to inhibit the growth of Gram negative and Gram positive reference strains.</p><p id="Par23">The data presented here shows that <italic>Exiguobacterium</italic> sp. RIT452 produces a broad spectrum antibiotic, which after fractionating by differential extraction and chromatography, was not structurally characterized. The facultative anaerobic Gram-positive genus <italic>Exiguobacterium</italic> consists of motile, non-spore forming species [<xref ref-type="bibr" rid="CR15">15</xref>], widely distributed in the environment, including extremophiles growing in high altitude salt plains [<xref ref-type="bibr" rid="CR16">16</xref>], hot springs [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>], oceans, Antarctic dry valleys and permafrost [<xref ref-type="bibr" rid="CR18">18</xref>], while others tolerate gamma radiation [<xref ref-type="bibr" rid="CR19">19</xref>], organic solvents [<xref ref-type="bibr" rid="CR20">20</xref>], chromium and mercury [<xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref>], arsenic [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR24">24</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref>], pesticides [<xref ref-type="bibr" rid="CR27">27</xref>], alkaline wastewater [<xref ref-type="bibr" rid="CR28">28</xref>], and heat [<xref ref-type="bibr" rid="CR29">29</xref>&#x02013;<xref ref-type="bibr" rid="CR32">32</xref>]. All of this is accomplished without the ability to form spores, suggesting other physiological changes help them cope with these stresses.</p></sec><sec id="Sec2"><title>Main text</title><sec id="Sec3"><title>Methods</title><sec id="Sec4"><title>Bacterial growth and characterization</title><p id="Par24">Tryptic soy broth (TSB) cultures were used for DNA extraction, while LB (Lysogeny broth) was used for the antibiotic production cultures. R2A (Reasoner&#x02019;s 2A) minimal media were used for starvation experiments according to Yang et al. [<xref ref-type="bibr" rid="CR33">33</xref>]. Tryptic soy agar (TSA)-grown cells were analyzed after weeks 1 and 5 by electron microscopy to examine the morphological changes. RIT452 was identified as an <italic>Exiguobacterium</italic> sp. based on the 16S rRNA gene sequence. The V3/V4 region was sequenced by Sanger nucleotide sequencing (GeneWiz LLC, South Plainfield, NJ) and was analyzed by the basic local alignment search tool (BLAST) [<xref ref-type="bibr" rid="CR18">18</xref>].</p></sec><sec id="Sec5"><title>PCR amplification and nucleotide sequencing of the 16S V3/V4 regions</title><p id="Par25">Bacteria from ponds at the Rochester Institute of Technology (RIT) were isolated on TSA or R2A media. Each was subjected to PCR using primers, 5&#x02032;-CCTACGGGNGGCWCGAG-3&#x02032; (forward) and 5&#x02032;-GACTACHVGGGTATCTAATCC-3&#x02032; (reverse) designed to amplify the V3/V4 rRNA regions. The following thermal cycler protocol was used: 1 cycle at 95&#x000a0;&#x000b0;C for 2&#x000a0;min, 30 cycles each at 95&#x000a0;&#x000b0;C for 30&#x000a0;s, 52&#x000a0;&#x000b0;C for 30&#x000a0;s and 72&#x000a0;&#x000b0;C for 3&#x000a0;min, 1 cycle at 72&#x000a0;&#x000b0;C for 5&#x000a0;min, and finally infinite hold at 4&#x000a0;&#x000b0;C. The PCR products were separated by gel electrophoresis, followed by Sanger nucleotide sequencing of the amplified sequences (GeneWiz LLC, South Plainfield, NJ) prepared with the V3/V4 forward primer.</p></sec><sec id="Sec6"><title>Genomic DNA isolation, library preparation, genome sequencing and alignment</title><p id="Par26">RIT452 grown in 3&#x000a0;mL of TSB for 24&#x000a0;h at 30&#x000a0;&#x000b0;C. The DNA isolation and subsequent steps were performed as in Steiner et al. [<xref ref-type="bibr" rid="CR34">34</xref>].</p></sec><sec id="Sec7"><title>Predicting secondary metabolite production</title><p id="Par27">The aligned genome sequence of <italic>Exiguobacterium</italic> sp. RIT 452 was analyzed using the antibiotics and secondary metabolite analysis shell (antiSMASH4.0) webserver [<xref ref-type="bibr" rid="CR13">13</xref>]. The aligned genome was also analyzed by the antibiotic resistance target seeker (ARTS version 2) webserver [<xref ref-type="bibr" rid="CR14">14</xref>]. ARTS predicts resistance mechanisms and BGCs from genome sequences [<xref ref-type="bibr" rid="CR14">14</xref>].</p></sec><sec id="Sec8"><title>Extraction of organic compounds from culture media</title><p id="Par28">RIT 452 was cultured in 100&#x000a0;mL LB medium at 30&#x000a0;&#x000b0;C shaken at 130&#x000a0;rpm for 24&#x000a0;h. This was inoculated in 900&#x000a0;mL of LB medium and grown for an additional 48&#x000a0;h at 30&#x000a0;&#x000b0;C shaken at 130&#x000a0;rpm. The extraction of organics from the spent media and storage of concentrated extracts were performed as published earlier [<xref ref-type="bibr" rid="CR34">34</xref>].</p></sec><sec id="Sec9"><title>Compound fractionation and liquid chromatography (LC)</title><p id="Par29">A five-step extraction and the subsequent separation of the most active extract by liquid chromatography were conducted using known methods [<xref ref-type="bibr" rid="CR34">34</xref>].</p></sec><sec id="Sec10"><title>Broth dilution assay vs. clinical pathogens</title><p id="Par30">Three clinical pathogens were used: MRSA USA300-FPR3757 (<italic>mecA</italic>) [<xref ref-type="bibr" rid="CR35">35</xref>], <italic>E. coli</italic> MCR1_NJ [<italic>mcr-1, bla</italic><sub>NDM-5</sub><italic>, strA, strB, aac</italic>(6<italic>&#x02032;</italic>)<italic>-Ib-cr, bla</italic><sub>OXA-1</sub><italic>, arr-3, sul1, sul2, tet</italic>(A)] [<xref ref-type="bibr" rid="CR36">36</xref>], and <italic>P. aeruginosa</italic> AR-0230 (<italic>aac</italic>(3)<italic>-Id</italic>, <italic>aadA2</italic>, dfrB5, OXA-4, OXA-50, tet(G), VIM-2) [<xref ref-type="bibr" rid="CR37">37</xref>]. Briefly, experiments were conducted in cation adjusted Mueller Hinton broth and a starting bacterial inoculum of &#x02009;~&#x02009;10<sup>6</sup>&#x000a0;cfu/mL for each isolate. The minimum inhibitory concentration (MIC) for the crude extract against all three clinical isolates, determined using broth micro-dilution according to the Clinical and Laboratory Standards Institute (CLSI) Guidelines, was 6.25&#x000a0;&#x000d7;&#x000a0; (equivalent to metabolites extracted from 6.25&#x000a0;mL of spent media) [<xref ref-type="bibr" rid="CR38">38</xref>].</p></sec><sec id="Sec11"><title>Disc diffusion assays</title><p id="Par31">Disc diffusion tests of the organics extracted with different solvents was performed according to Steiner et al. [<xref ref-type="bibr" rid="CR34">34</xref>].</p></sec><sec id="Sec12"><title>Disc diffusion assays of LC fractions</title><p id="Par32">The activity was tested against <italic>E. coli</italic> ATCC 25922, <italic>P. aeruginosa</italic> ATCC 27853, <italic>B. subtilis</italic> BGSC 168 and <italic>S. aureus</italic> ATCC 25923. The activity was better against the Gram positive strains (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1). Further enrichment of the active compounds was performed with <italic>S. aureus</italic> ATCC 25923 as the test strain. <italic>S. aureus</italic> ATCC 25923 was grown overnight in 5&#x000a0;mL LB medium at 30&#x000a0;&#x000b0;C in a 130&#x000a0;rpm shaker incubator. The cells were pelleted and each culture was re-suspended in 2&#x000a0;mL of sterile PBS. 180&#x000a0;&#x003bc;L of the re-suspension was mixed into tubes containing 40&#x000a0;ml of warm LB agar and poured into square petri dishes. The petri plates were cooled for 1&#x000a0;h in a sterile hood. 6&#x000a0;mm sterile blank paper disks (BD Biosciences, USA) were aseptically placed onto each agar plate. Methanol (20&#x000a0;&#x003bc;L), tetracycline stock (10&#x000a0;mg/mL, 22.5&#x000a0;&#x003bc;M, 20&#x000a0;&#x003bc;L), and each fraction (60&#x000a0;&#x003bc;L of each fraction re-suspended in 100&#x000a0;&#x003bc;L methanol) were pipetted onto the disks. The plates were dried aseptically for 1&#x000a0;h and incubated for 16&#x000a0;h at 30&#x000a0;&#x000b0;C. The diameter of each zone of inhibition (ZOI) was measured in mm.</p></sec><sec id="Sec13"><title>Flow injection analysis (FIA) and liquid chromatography-mass spectrometry (LCMS)</title><p id="Par33">Low resolution mass spectrometry data was obtained on an Agilent LC/MSD VL system by electrospray ionization (ESI) flow injection analysis in the (positive or negative) mode at the Boston University Chemical Instrumentation Center. A reverse-phase C18 Zorbax Eclipse 2.1&#x02009;&#x000d7;&#x02009;50&#x000a0;mm column (Agilent) was used, and the mobile phases were water and acetonitrile with 0.1% formic acid. Separation was achieved by a flow rate of 0.15&#x000a0;mL/min and a mobile phase gradient from 5 to 95% acetonitrile in 10&#x000a0;min. The MS settings were: voltage &#x02009;=&#x02009; 3000&#x000a0;V, fragmentor &#x02009;=&#x02009; 70 and chamber temperature &#x02009;=&#x02009; 350&#x000a0;&#x000b0;C.</p></sec><sec id="Sec14"><title>Scanning electron microscopy (SEM)</title><p id="Par34">The microbiological sample preparation followed an open source protocol [<xref ref-type="bibr" rid="CR39">39</xref>]. Samples were covered with gold&#x02013;palladium for 2&#x000a0;minutes with an SPI sputter coater to mitigate charging in the electron beam. The SEM was performed at 5&#x000a0;kV using a Mira3Tescan field emission SEM at the Rochester Institute of Technology (RIT) Nano-Imaging Lab.</p></sec></sec></sec><sec id="Sec15"><title>Results</title><sec id="Sec16"><title>Strain characterization and phylogeny</title><p id="Par35">The genome was sequenced using an Illumina MiSeq. After assembly, the genome sequence has been deposited in GenBank under accession number QXJB00000000 (BioProject number PRJNA489292; BioSample number SAMN09954399).</p></sec><sec id="Sec17"><title>Electron microscopy analysis</title><p id="Par36">RIT452 grown on solid media under different conditions and Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> shows the scanning electron microscopy (SEM) images recorded for each. In minimal media [<xref ref-type="bibr" rid="CR33">33</xref>], the cells grow longer, closer to 2&#x000a0;&#x000b5;m, and form larger aggregates (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>A). Healthy cells are around 1&#x000a0;&#x000b5;m in length and around 0.5&#x000a0;&#x000b5;m wide (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>B); However when healthy cells are grown for prolonged periods in rich broth media, the cell surface alters and appears rougher (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>C).<fig id="Fig1"><label>Fig. 1</label><caption><p>SEM analysis. <italic>Exiguobacterium</italic> RIT452 under different conditions. <bold>A</bold> Cell elongation observed due to starvation on R2A (minimal medium); <bold>B</bold> cells grown on TSA for 1&#x000a0;week and <bold>C</bold> cells grown on TSA for 5&#x000a0;weeks. The magnifications are 9830&#x02009;&#x000d7;, 26,500&#x02009;&#x000d7;, and 44,900&#x02009;&#x000d7;, respectively</p></caption><graphic xlink:href="13104_2021_5644_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec18"><title>antiSMASH and ARTS results</title><p id="Par37">The antiSMASH 5.0 web tool analyzes genome sequences and predicts the secondary metabolites produced by an organism [<xref ref-type="bibr" rid="CR13">13</xref>]. antiSMASH predicted that RIT452 contained four biosynthetic gene clusters (BGCs), two terpene clusters, a siderophore cluster, and a putative antibiotic cluster (Table <xref rid="Tab1" ref-type="table">1</xref>). The &#x0201c;putative antibiotic&#x0201d; BGC identified at locus 897206&#x02013;908755 shares sequence similarity with a Lugdunin locus, an antibiotic first isolated from <italic>S. lugdunensis</italic>, a commensal of the human nasal cavity [<xref ref-type="bibr" rid="CR40">40</xref>]. This novel thiazolidine-containing cyclic peptide antimicrobial was shown to be effective against <italic>S. aureus.</italic> Using the genome sequence of RIT 452, ARTS predicted three BGCs, out of which two show &#x0201c;proximity hits&#x0201d; (Table <xref rid="Tab1" ref-type="table">1</xref>). The &#x0201c;proximity hits&#x0201d; readout in the ARTS program shows scaffold-specific self-resistance [<xref ref-type="bibr" rid="CR14">14</xref>], which is considered a good way to mine for novel antibiotic BGCs [<xref ref-type="bibr" rid="CR41">41</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p>Secondary metabolites predicted by antiSMASH 5.0 genome mining</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Cluster no.</th><th align="left">Predicted biosynthetic metabolite</th><th align="left">Coordinates within the genome</th><th align="left">% Similarity to known cluster</th><th align="left">ARTS BGC proximity hits</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">Terpene</td><td char="&#x02013;" align="char">69,899&#x02013;90,726</td><td align="left">33 (with carotenoid biosynthetic gene cluster)</td><td align="left">&#x02013;</td></tr><tr><td align="left">4</td><td align="left">Siderophore</td><td char="&#x02013;" align="char">5,05,835&#x02013;5,19,165</td><td align="left">&#x02013;</td><td align="left">Yes</td></tr><tr><td align="left">9</td><td align="left">Putative antibiotic</td><td char="&#x02013;" align="char">8,97,206&#x02013;9,08,755</td><td align="left">26 (with lugdunin biosynthetic gene cluster)</td><td align="left"/></tr><tr><td align="left">20</td><td align="left">Terpene</td><td char="&#x02013;" align="char">1,60,337&#x02013;1,81,161</td><td align="left">&#x02013;</td><td align="left">Yes</td></tr></tbody></table><table-wrap-foot><p>The compounds shown in this table show four of the 24 compounds antiSMASH predicted, which could potentially exhibit antibiotic characteristics. If core and resistance genes have intersecting locations on the same scaffold as predicted by ARTS, they are marked as BGC proximity hits</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec19"><title>Broth dilution assays</title><p id="Par38">The crude extract from 1&#x000a0;Liter of spent RIT 452 media was able to inhibit the pathogens MRSA, <italic>E. coli</italic> ncr1_NJ, and <italic>P. aeruginosa</italic> AR-230 at moderate concentrations and the apparent minimum inhibitory concentrations (MIC) in each case is shown in the Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1.</p></sec><sec id="Sec20"><title>Disc diffusion assays</title><p id="Par39">Crude ethyl acetate extract from spent LB media was spotted on sterile discs and plated on LB agar seeded with different species of bacteria which are not clinical pathogens, whereby the extract inhibited the growth of all strains tested (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1). The zones of inhibition (ZOIs) show a graded increase with increased volume of extract. The dose response curve created using the ZOIs shows that the extract inhibited the growth of <italic>S. aureus, E. coli,</italic> and <italic>P. aeruginosa</italic> along roughly the same trend while <italic>B. subtilis</italic> had a steeper increase in dosage response (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1). Among the crude extracts obtained by processing with hexanes, toluene, ether, dichloromethane and ethyl acetate, only one fraction (diethyl ether) showed a ZOI.</p></sec><sec id="Sec21"><title>Enrichment of active metabolites using liquid chromatography</title><p id="Par40">The diethyl ether extract when subjected to liquid chromatography using a C18 column (see methods) with <italic>S. aureus</italic> as the test strain. The extract when fractionated showed activity only in fraction 32 (ZOI &#x02009;=&#x02009; 15&#x000a0;mm), corresponding to a single peak in the LC channel of the LCMS (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>A), but at least four ionizable species in the positive scan mode (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>B). The largest peak corresponding to 0.652&#x000a0;min shows the masses 335.5, 401.7 and 445.6 in the positive scan mode. The active compound(s) were not further characterized.<fig id="Fig2"><label>Fig. 2</label><caption><p>Disc assay using LC fractions 31&#x02013;36 from diethyl ether extraction and LCMS data. <bold>A</bold> The LC protocol was run to collect fractions of the RIT452 diethyl ether extract. Each was condensed, fully dried, and re-suspended in 100&#x000a0;&#x000b5;l of methanol. 60&#x000a0;&#x000b5;l of each fraction was added to a sterile diffusion disc and plated on LB agar seeded with <italic>S. aureus</italic>. The zone of inhibition (ZOI) of fraction 32 is 15&#x000a0;mm after 16&#x000a0;h of growth. <bold>B</bold> The LC channel in the LCMS shows only one chromatographic peak, while the MS channel shows at least four ionizable species in the positive scan mode. <bold>C</bold> The MS pattern corresponding to the beginning of the largest MS peak (0.652&#x000a0;min) in <bold>B</bold> shows the peaks 335.5, 401.7 and 445.6 in the positive scan mode between 100 and 1000&#x000a0;m/z</p></caption><graphic xlink:href="13104_2021_5644_Fig2_HTML" id="MO2"/></fig></p></sec></sec><sec id="Sec22"><title>Discussion</title><p id="Par41"><italic>Exiguobacterium</italic> strains have been previously reported to nearly triple their cell length after exposure to organic solvents [<xref ref-type="bibr" rid="CR20">20</xref>], whereas RIT452 also undergoes cell elongation upon starvation. This suggests that cell elongation might be a generic stress response in the <italic>Exigobacterium</italic> genus. However, it is not known if this response also occurs as a result of interaction with other bacteria.</p><p id="Par42">An Indian rhizosphere <italic>Exiguobacterium</italic> strain produces a broad spectrum with an unusual dihydroergotamine-type antibiotic [<xref ref-type="bibr" rid="CR42">42</xref>], apart from which little is known about bioactive compounds produced by the genus <italic>Exiguobacterium</italic>. The diversity of microbial metabolites may be partly underestimated, since each BGC does not necessarily produce only one metabolite, and growth conditions may change the metabolite produced by altering the expression of the same BGC [<xref ref-type="bibr" rid="CR43">43</xref>]. Sequence identity at the level of genes in BGC producing similar compounds were reported to range between 58 and 80% [<xref ref-type="bibr" rid="CR44">44</xref>]. By these criteria, the similarity to known BGC for our data is not very high, suggesting potential novelty.</p><p id="Par43">The suggestion of metabolite novelty is encouraging since the RIT 452 extract contains compound(s) inhibiting a Gram positive clinical strain (MRSA) at lower concentrations (apparent MIC) than Gram negative clinical strains (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). Fractionation of the extracts using a non-clinical <italic>S. aureus</italic> strain shows that the activity is concentrated in the range of 95% acetonitrile, which hints at a relatively non-polar compound. Further &#x0201c;wet lab&#x0201d; experiments are needed to identify the bioactive compound(s) to verify the predictions made by bioinformatics analysis.</p></sec><sec id="Sec23"><title>Limitations</title><p id="Par44">The active fraction contains more than one ionizable species and the chemical structure/s of the active compound/s are still unknown. MIC values and safety data of the isolated compound are also unknown.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Information</title><sec id="Sec24"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13104_2021_5644_MOESM1_ESM.docx"><caption><p><bold>Additional file 1: Figure S1.</bold> A&#x02013;D: Disc diffusion assay. RIT452 extracts (on discs) inhibit the growth of (A)<italic> E. coli</italic>, (B) <italic>S. aureus</italic>, (C) <italic>P. aeruginosa</italic>, and (D) <italic>B. subtilis</italic>. On each plate from top left to right the discs have 20 &#x000b5;l Tetracycline at 10 mg/ml (1), 10 &#x000b5;l extract (2), 20 &#x000b5;l extract (3), 40 &#x000b5;l extract (4), 60 &#x000b5;l extract (5), and 20 &#x000b5;l methanol as a negative control (6). (E) The inhibition zones in each case show a graded increase in the diameter of the zone of inhibition with increasing amounts of extract. Error bars from triplicate readings are shown and it can be seen that the linear range goes approximately up to 20 &#x000b5;L. <bold>Table S1.</bold> Estimated apparent MICs of the RIT 452 crude extracts computed according to the CLSI guidelines.</p></caption></media></supplementary-material></p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>antiSMASH</term><def><p id="Par3">Antibiotics and secondary metabolite analysis shell</p></def></def-item><def-item><term>ARTS</term><def><p id="Par4">Antibiotic resistance target seeker</p></def></def-item><def-item><term>BGC</term><def><p id="Par5">Biosynthetic gene cluster</p></def></def-item><def-item><term>CLSI</term><def><p id="Par6">Clinical and Laboratory Standards Institute</p></def></def-item><def-item><term>ESI</term><def><p id="Par7">Electrospray ionization</p></def></def-item><def-item><term>LB</term><def><p id="Par8">Lysogeny broth</p></def></def-item><def-item><term>LC</term><def><p id="Par9">Liquid chromatography</p></def></def-item><def-item><term>LCMS</term><def><p id="Par10">Liquid chromatography-mass spectrometry</p></def></def-item><def-item><term>MIC</term><def><p id="Par11">Minimum inhibitory concentration</p></def></def-item><def-item><term>MRSA</term><def><p id="Par12">Methicillin resistant <italic>Staphylococcus aureus</italic></p></def></def-item><def-item><term>MS</term><def><p id="Par13">Mass spectrometry</p></def></def-item><def-item><term>R2A</term><def><p id="Par14">Reasoner&#x02019;s 2A</p></def></def-item><def-item><term>RIT</term><def><p id="Par15">Rochester Institute of Technology</p></def></def-item><def-item><term>SEM</term><def><p id="Par16">Scanning electron microscopy</p></def></def-item><def-item><term>TSA</term><def><p id="Par17">Tryptic soy agar</p></def></def-item><def-item><term>TSB</term><def><p id="Par18">Tryptic soy broth</p></def></def-item><def-item><term>ZOI</term><def><p id="Par19">Zone of inhibition</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank Prof. Richard Hailstone Center for Imaging Sciences at RIT for help with the SEM analysis, and Norman Lee of the Boston University Chemical Instrumentation Center for running and analyzing the LC-MS samples. We thank Dr. Zachary P. Bulman of the College of Pharmacy, University of Illinois at Chicago, for performing the broth dilution assays with the clinical strains.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>Research was conducted by NTC. The manuscript was written by NTC, AP and AOH. NHW helped with whole-genome sequencing and phylogenetic analysis. KKS helped isolate the bacterium and JC helped with liquid chromatography. JA performed assays to facilitate resubmission. The study was designed by AOH and the extraction, chromatography and SEM methods were developed by AP. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This research was funded by a National Institutes of Health award (RG15GM120653) to AOH.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The whole-genome project for <italic>Exiguobacterium</italic> sp. RIT452 is available in GenBank with the accession number QXJB00000000.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par45">Not applicable.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par46">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par47">The authors declare no competing interest.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ventola</surname><given-names>CL</given-names></name></person-group><article-title>The antibiotic resistance crisis: part 1: causes and threats</article-title><source>P T</source><year>2015</year><volume>40</volume><fpage>277</fpage><lpage>83</lpage><?supplied-pmid 25859123?><pub-id pub-id-type="pmid">25859123</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thornsberry</surname><given-names>C</given-names></name><name><surname>Sahm</surname><given-names>DF</given-names></name><name><surname>Kelly</surname><given-names>LJ</given-names></name><name><surname>Critchley</surname><given-names>IA</given-names></name><name><surname>Jones</surname><given-names>ME</given-names></name><name><surname>Evangelista</surname><given-names>AT</given-names></name><name><surname>Karlowsky</surname><given-names>JA</given-names></name></person-group><article-title>Regional trends in antimicrobial resistance among clinical isolates of <italic>Streptococcus pneumoniae</italic>, <italic>Haemophilus influenzae</italic>, and <italic>Moraxella catarrhalis</italic> in the United States: results from the TRUST Surveillance Program, 1999&#x02013;2000</article-title><source>Clin Infect Dis</source><year>2002</year><volume>34</volume><issue>Suppl 1</issue><fpage>S4</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1086/324525</pub-id><pub-id pub-id-type="pmid">11810606</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palumbi</surname><given-names>SR</given-names></name></person-group><article-title>Humans as the world&#x02019;s greatest evolutionary force</article-title><source>Science</source><year>2001</year><volume>293</volume><fpage>1786</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1126/science.293.5536.1786</pub-id><pub-id pub-id-type="pmid">11546863</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>C</given-names></name></person-group><source>Antibiotics: actions, origins, resistance</source><year>2003</year><publisher-loc>USA</publisher-loc><publisher-name>ASM Press</publisher-name></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coates</surname><given-names>A</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Bax</surname><given-names>R</given-names></name><name><surname>Page</surname><given-names>C</given-names></name></person-group><article-title>The future challenges facing the development of new antimicrobial drugs</article-title><source>Nat Rev Drug Discov</source><year>2002</year><volume>1</volume><fpage>895</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1038/nrd940</pub-id><pub-id pub-id-type="pmid">12415249</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ventola</surname><given-names>CL</given-names></name></person-group><article-title>The antibiotic resistance crisis: part 2: management strategies and new agents</article-title><source>P T</source><year>2015</year><volume>40</volume><fpage>344</fpage><lpage>52</lpage><?supplied-pmid 25987823?><pub-id pub-id-type="pmid">25987823</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghafourian</surname><given-names>S</given-names></name><name><surname>Sadeghifard</surname><given-names>N</given-names></name><name><surname>Soheili</surname><given-names>S</given-names></name><name><surname>Sekawi</surname><given-names>Z</given-names></name></person-group><article-title>Extended spectrum beta-lactamases: definition, classification and epidemiology</article-title><source>Curr Issues Mol Biol</source><year>2015</year><volume>17</volume><fpage>11</fpage><lpage>21</lpage><?supplied-pmid 24821872?><pub-id pub-id-type="pmid">24821872</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohacek</surname><given-names>RS</given-names></name><name><surname>McMartin</surname><given-names>C</given-names></name><name><surname>Guida</surname><given-names>WC</given-names></name></person-group><article-title>The art and practice of structure-based drug design: a molecular modeling perspective</article-title><source>Med Res Rev</source><year>1996</year><volume>16</volume><fpage>3</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1098-1128(199601)16:1&#x0003c;3::AID-MED1&#x0003e;3.0.CO;2-6</pub-id><pub-id pub-id-type="pmid">8788213</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipinski</surname><given-names>C</given-names></name><name><surname>Hopkins</surname><given-names>A</given-names></name></person-group><article-title>Navigating chemical space for biology and medicine</article-title><source>Nature</source><year>2004</year><volume>432</volume><fpage>855</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1038/nature03193</pub-id><pub-id pub-id-type="pmid">15602551</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipinski</surname><given-names>CA</given-names></name><name><surname>Lombardo</surname><given-names>F</given-names></name><name><surname>Dominy</surname><given-names>BW</given-names></name><name><surname>Feeney</surname><given-names>PJ</given-names></name></person-group><article-title>Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</article-title><source>Adv Drug Deliv Rev</source><year>2001</year><volume>46</volume><fpage>3</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/S0169-409X(00)00129-0</pub-id><pub-id pub-id-type="pmid">11259830</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skinnider</surname><given-names>MA</given-names></name><name><surname>Magarvey</surname><given-names>NA</given-names></name></person-group><article-title>Statistical reanalysis of natural products reveals increasing chemical diversity</article-title><source>Proc Natl Acad Sci</source><year>2017</year><volume>114</volume><fpage>E6271</fpage><pub-id pub-id-type="doi">10.1073/pnas.1708560114</pub-id><pub-id pub-id-type="pmid">28710332</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smanski</surname><given-names>MJ</given-names></name><name><surname>Schlatter</surname><given-names>DC</given-names></name><name><surname>Kinkel</surname><given-names>LL</given-names></name></person-group><article-title>Leveraging ecological theory to guide natural product discovery</article-title><source>J Ind Microbiol Biotechnol</source><year>2016</year><volume>43</volume><fpage>115</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1007/s10295-015-1683-9</pub-id><pub-id pub-id-type="pmid">26434742</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blin</surname><given-names>K</given-names></name><name><surname>Shaw</surname><given-names>S</given-names></name><name><surname>Steinke</surname><given-names>K</given-names></name><name><surname>Villebro</surname><given-names>R</given-names></name><name><surname>Ziemert</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Medema</surname><given-names>MH</given-names></name><name><surname>Weber</surname><given-names>T</given-names></name></person-group><article-title>antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline</article-title><source>Nucleic Acids Res</source><year>2019</year><volume>47</volume><fpage>W81</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz310</pub-id><pub-id pub-id-type="pmid">31032519</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alanjary</surname><given-names>M</given-names></name><name><surname>Kronmiller</surname><given-names>B</given-names></name><name><surname>Adamek</surname><given-names>M</given-names></name><name><surname>Blin</surname><given-names>K</given-names></name><name><surname>Weber</surname><given-names>T</given-names></name><name><surname>Huson</surname><given-names>D</given-names></name><name><surname>Philmus</surname><given-names>B</given-names></name><name><surname>Ziemert</surname><given-names>N</given-names></name></person-group><article-title>The antibiotic resistant target seeker (ARTS), an exploration engine for antibiotic cluster prioritization and novel drug target discovery</article-title><source>Nucleic Acids Res</source><year>2017</year><volume>45</volume><fpage>W42</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx360</pub-id><pub-id pub-id-type="pmid">28472505</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>MD</given-names></name><name><surname>Lund</surname><given-names>BM</given-names></name><name><surname>Farrow</surname><given-names>JAE</given-names></name><name><surname>Schleifer</surname><given-names>KH</given-names></name></person-group><article-title>Chemotaxonomic study of an alkalophilic bacterium, <italic>Exiguobacterium aurantiacum</italic> gen. nov., sp. nov</article-title><source>Microbiology</source><year>1983</year><volume>129</volume><fpage>2037</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1099/00221287-129-7-2037</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro-Severyn</surname><given-names>J</given-names></name><name><surname>Remonsellez</surname><given-names>F</given-names></name><name><surname>Valenzuela</surname><given-names>SL</given-names></name><name><surname>Salinas</surname><given-names>C</given-names></name><name><surname>Fortt</surname><given-names>J</given-names></name><name><surname>Aguilar</surname><given-names>P</given-names></name><name><surname>Pardo-Est&#x000e9;</surname><given-names>C</given-names></name><name><surname>Dorador</surname><given-names>C</given-names></name><name><surname>Quatrini</surname><given-names>R</given-names></name><name><surname>Molina</surname><given-names>F</given-names></name><name><surname>Aguayo</surname><given-names>D</given-names></name><name><surname>Castro-Nallar</surname><given-names>E</given-names></name><name><surname>Saavedra</surname><given-names>CP</given-names></name></person-group><article-title>Comparative genomics analysis of a new <italic>Exiguobacterium</italic> strain from Salar de Huasco Reveals a repertoire of stress-related genes and arsenic resistance</article-title><source>Front Microbiol</source><year>2017</year><volume>8</volume><fpage>456</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.00456</pub-id><pub-id pub-id-type="pmid">28377753</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vishnivetskaya</surname><given-names>TA</given-names></name><name><surname>Lucas</surname><given-names>S</given-names></name><name><surname>Copeland</surname><given-names>A</given-names></name><name><surname>Lapidus</surname><given-names>A</given-names></name><name><surname>Glavina del Rio</surname><given-names>T</given-names></name><name><surname>Dalin</surname><given-names>E</given-names></name><name><surname>Tice</surname><given-names>H</given-names></name><name><surname>Bruce</surname><given-names>DC</given-names></name><name><surname>Goodwin</surname><given-names>LA</given-names></name><name><surname>Pitluck</surname><given-names>S</given-names></name><name><surname>Saunders</surname><given-names>E</given-names></name><name><surname>Brettin</surname><given-names>T</given-names></name><name><surname>Detter</surname><given-names>C</given-names></name><name><surname>Han</surname><given-names>C</given-names></name><name><surname>Larimer</surname><given-names>F</given-names></name><name><surname>Land</surname><given-names>ML</given-names></name><name><surname>Hauser</surname><given-names>LJ</given-names></name><name><surname>Kyrpides</surname><given-names>NC</given-names></name><name><surname>Ovchinnikova</surname><given-names>G</given-names></name><name><surname>Kathariou</surname><given-names>S</given-names></name><name><surname>Ramaley</surname><given-names>RF</given-names></name><name><surname>Rodrigues</surname><given-names>DF</given-names></name><name><surname>Hendrix</surname><given-names>C</given-names></name><name><surname>Richardson</surname><given-names>P</given-names></name><name><surname>Tiedje</surname><given-names>JM</given-names></name></person-group><article-title>Complete genome sequence of the thermophilic bacterium <italic>Exiguobacterium</italic> sp. AT1b</article-title><source>J Bacteriol</source><year>2011</year><volume>193</volume><fpage>2880</fpage><lpage>1</lpage><pub-id pub-id-type="doi">10.1128/JB.00303-11</pub-id><pub-id pub-id-type="pmid">21460088</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vishnivetskaya</surname><given-names>TA</given-names></name><name><surname>Chauhan</surname><given-names>A</given-names></name><name><surname>Layton</surname><given-names>AC</given-names></name><name><surname>Pfiffner</surname><given-names>SM</given-names></name><name><surname>Huntemann</surname><given-names>M</given-names></name><name><surname>Copeland</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name><name><surname>Kyrpides</surname><given-names>NC</given-names></name><name><surname>Markowitz</surname><given-names>VM</given-names></name><name><surname>Palaniappan</surname><given-names>K</given-names></name><name><surname>Ivanova</surname><given-names>N</given-names></name><name><surname>Mikhailova</surname><given-names>N</given-names></name><name><surname>Ovchinnikova</surname><given-names>G</given-names></name><name><surname>Andersen</surname><given-names>EW</given-names></name><name><surname>Pati</surname><given-names>A</given-names></name><name><surname>Stamatis</surname><given-names>D</given-names></name><name><surname>Reddy</surname><given-names>TB</given-names></name><name><surname>Shapiro</surname><given-names>N</given-names></name><name><surname>Nordberg</surname><given-names>HP</given-names></name><name><surname>Cantor</surname><given-names>MN</given-names></name><name><surname>Hua</surname><given-names>XS</given-names></name><name><surname>Woyke</surname><given-names>T</given-names></name></person-group><article-title>Draft genome sequences of 10 strains of the genus <italic>Exiguobacterium</italic></article-title><source>Genome Announc</source><year>2014</year><pub-id pub-id-type="doi">10.1128/genomeA.01058-14</pub-id><?supplied-pmid 25414511?><pub-id pub-id-type="pmid">25414511</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pathak</surname><given-names>R</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Gautam</surname><given-names>HK</given-names></name></person-group><article-title>Cross-species induction and enhancement of antimicrobial properties in response to gamma irradiation in <italic>Exiguobacterium</italic> sp. HKG 126</article-title><source>Indian J Microbiol</source><year>2013</year><volume>53</volume><fpage>130</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1007/s12088-013-0369-0</pub-id><pub-id pub-id-type="pmid">24426098</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kongpol</surname><given-names>A</given-names></name><name><surname>Kato</surname><given-names>J</given-names></name><name><surname>Tajima</surname><given-names>T</given-names></name><name><surname>Vangnai</surname><given-names>AS</given-names></name></person-group><article-title>Characterization of acetonitrile-tolerant marine bacterium <italic>Exiguobacterium</italic> sp. SBH81 and its tolerance mechanism</article-title><source>Microbes Environ</source><year>2012</year><volume>27</volume><fpage>30</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1264/jsme2.ME11228</pub-id><pub-id pub-id-type="pmid">21971080</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pattanapipitpaisal</surname><given-names>P</given-names></name><name><surname>Mabbett</surname><given-names>AN</given-names></name><name><surname>Finlay</surname><given-names>JA</given-names></name><name><surname>Beswick</surname><given-names>AJ</given-names></name><name><surname>Paterson-Beedle</surname><given-names>M</given-names></name><name><surname>Essa</surname><given-names>A</given-names></name><name><surname>Wright</surname><given-names>J</given-names></name><name><surname>Tolley</surname><given-names>MR</given-names></name><name><surname>Badar</surname><given-names>U</given-names></name><name><surname>Ahmed</surname><given-names>N</given-names></name><name><surname>Hobman</surname><given-names>JL</given-names></name><name><surname>Brown</surname><given-names>NL</given-names></name><name><surname>Macaskie</surname><given-names>LE</given-names></name></person-group><article-title>Reduction of Cr(VI) and bioaccumulation of chromium by gram positive and gram negative microorganisms not previously exposed to Cr-stress</article-title><source>Environ Technol</source><year>2002</year><volume>23</volume><fpage>731</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1080/09593332308618367</pub-id><pub-id pub-id-type="pmid">12164635</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okeke</surname><given-names>BC</given-names></name></person-group><article-title>Bioremoval of hexavalent chromium from water by a salt tolerant bacterium, <italic>Exiguobacterium</italic> sp. GS1</article-title><source>J Ind Microbiol Biotechnol</source><year>2008</year><volume>35</volume><fpage>1571</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s10295-008-0399-5</pub-id><pub-id pub-id-type="pmid">18663504</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrova</surname><given-names>MA</given-names></name><name><surname>Mindlin</surname><given-names>SZ</given-names></name><name><surname>Gorlenko</surname><given-names>ZM</given-names></name><name><surname>Kaliaeva</surname><given-names>ES</given-names></name><name><surname>Soina</surname><given-names>VS</given-names></name><name><surname>Bogdanova</surname><given-names>ES</given-names></name></person-group><article-title>Mercury-resistant bacteria from permafrost sediments and prospects for their use in comparative studies of mercury resistance determinants</article-title><source>Genetika</source><year>2002</year><volume>38</volume><fpage>1569</fpage><lpage>74</lpage><?supplied-pmid 12500685?><pub-id pub-id-type="pmid">12500685</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>CR</given-names></name><name><surname>Cook</surname><given-names>GM</given-names></name></person-group><article-title>Isolation and characterization of arsenate-reducing bacteria from arsenic-contaminated sites in New Zealand</article-title><source>Curr Microbiol</source><year>2004</year><volume>48</volume><fpage>341</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1007/s00284-003-4205-3</pub-id><pub-id pub-id-type="pmid">15060729</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ordo&#x000f1;ez</surname><given-names>OF</given-names></name><name><surname>Rasuk</surname><given-names>MC</given-names></name><name><surname>Soria</surname><given-names>MN</given-names></name><name><surname>Contreras</surname><given-names>M</given-names></name><name><surname>Far&#x000ed;as</surname><given-names>ME</given-names></name></person-group><article-title>Haloarchaea from the Andean Puna: biological role in the energy metabolism of arsenic</article-title><source>Microb Ecol</source><year>2018</year><pub-id pub-id-type="doi">10.1007/s00248-018-1159-3</pub-id><?supplied-pmid 29520450?><pub-id pub-id-type="pmid">29520450</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belfiore</surname><given-names>C</given-names></name><name><surname>Ordo&#x000f1;ez</surname><given-names>OF</given-names></name><name><surname>Far&#x000ed;as</surname><given-names>ME</given-names></name></person-group><article-title>Proteomic approach of adaptive response to arsenic stress in <italic>Exiguobacterium</italic> sp. S17, an extremophile strain isolated from a high-altitude Andean lake stromatolite</article-title><source>Extremophiles</source><year>2013</year><volume>17</volume><fpage>421</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1007/s00792-013-0523-y</pub-id><pub-id pub-id-type="pmid">23525943</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Kumar A, Singh V, Kumar R. Characterization of an alkaliphile, <italic>Exiguobacterium</italic> sp. and it&#x02019;s application in bioremediation. p 115. <ext-link ext-link-type="uri" xlink:href="https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.128.2541&#x00026;rep=rep1&#x00026;type=pdf#page=114">https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.128.2541&#x00026;rep=rep1&#x00026;type=pdf#page=114</ext-link></mixed-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez</surname><given-names>L</given-names></name><name><surname>Pozo</surname><given-names>C</given-names></name><name><surname>Rodelas</surname><given-names>B</given-names></name><name><surname>Calvo</surname><given-names>C</given-names></name><name><surname>Ju&#x000e1;rez</surname><given-names>B</given-names></name><name><surname>Mart&#x000ed;nez-Toledo</surname><given-names>MV</given-names></name><name><surname>Gonz&#x000e1;lez-L&#x000f3;pez</surname><given-names>J</given-names></name></person-group><article-title>Identification of bacteria isolated from an oligotrophic lake with pesticide removal capacities</article-title><source>Ecotoxicology</source><year>2005</year><volume>14</volume><fpage>299</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1007/s10646-003-6367-y</pub-id><pub-id pub-id-type="pmid">15943106</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usuda</surname><given-names>Y</given-names></name><name><surname>Kawasaki</surname><given-names>H</given-names></name><name><surname>Shimaoka</surname><given-names>M</given-names></name><name><surname>Utagawa</surname><given-names>T</given-names></name></person-group><article-title>Molecular characterization of guanosine kinase gene from a facultative alkalophile, <italic>Exiguobacterium aurantiacum</italic> ATCC 35652</article-title><source>Biochim Biophys Acta</source><year>1998</year><volume>1442</volume><fpage>373</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/S0167-4781(98)00166-3</pub-id><pub-id pub-id-type="pmid">9804993</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suga</surname><given-names>S</given-names></name><name><surname>Koyama</surname><given-names>N</given-names></name></person-group><article-title>Purification and properties of a novel azide-sensitive ATPase of <italic>Exiguobacterium aurantiacum</italic></article-title><source>Arch Microbiol</source><year>2000</year><volume>173</volume><fpage>200</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1007/s002039900129</pub-id><pub-id pub-id-type="pmid">10763752</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasana</surname><given-names>RC</given-names></name><name><surname>Pandey</surname><given-names>CB</given-names></name></person-group><article-title><italic>Exiguobacterium</italic>: an overview of a versatile genus with potential in industry and agriculture</article-title><source>Crit Rev Biotechnol</source><year>2018</year><volume>38</volume><fpage>141</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1080/07388551.2017.1312273</pub-id><pub-id pub-id-type="pmid">28395514</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasana</surname><given-names>RC</given-names></name><name><surname>Yadav</surname><given-names>SK</given-names></name></person-group><article-title>Isolation of a psychrotrophic <italic>Exiguobacterium</italic> sp. SKPB5 (MTCC 7803) and characterization of its alkaline protease</article-title><source>Curr Microbiol</source><year>2007</year><volume>54</volume><fpage>224</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s00284-006-0402-1</pub-id><pub-id pub-id-type="pmid">17294327</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>WM</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>R</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name></person-group><article-title>Biodegradation and mineralization of polystyrene by plastic-eating mealworms: part 2. role of gut microorganisms</article-title><source>Environ Sci Technol</source><year>2015</year><volume>49</volume><fpage>12087</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1021/acs.est.5b02663</pub-id><pub-id pub-id-type="pmid">26390390</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>KK</given-names></name><name><surname>Parthasarathy</surname><given-names>A</given-names></name><name><surname>Wong</surname><given-names>NH</given-names></name><name><surname>Cavanaugh</surname><given-names>NT</given-names></name><name><surname>Chu</surname><given-names>J</given-names></name><name><surname>Hudson</surname><given-names>AO</given-names></name></person-group><article-title>Isolation and whole-genome sequencing of <italic>Pseudomonas</italic> sp. RIT 623, a slow-growing bacterium endowed with antibiotic properties</article-title><source>BMC Res Notes</source><year>2020</year><volume>13</volume><fpage>370</fpage><pub-id pub-id-type="doi">10.1186/s13104-020-05216-w</pub-id><pub-id pub-id-type="pmid">32746897</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diep</surname><given-names>BA</given-names></name><name><surname>Gill</surname><given-names>SR</given-names></name><name><surname>Chang</surname><given-names>RF</given-names></name><name><surname>Phan</surname><given-names>TH</given-names></name><name><surname>Chen</surname><given-names>JH</given-names></name><name><surname>Davidson</surname><given-names>MG</given-names></name><name><surname>Lin</surname><given-names>F</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Carleton</surname><given-names>HA</given-names></name><name><surname>Mongodin</surname><given-names>EF</given-names></name><name><surname>Sensabaugh</surname><given-names>GF</given-names></name><name><surname>Perdreau-Remington</surname><given-names>F</given-names></name></person-group><article-title>Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant <italic>Staphylococcus aureus</italic></article-title><source>Lancet</source><year>2006</year><volume>367</volume><fpage>731</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(06)68231-7</pub-id><pub-id pub-id-type="pmid">16517273</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mediavilla</surname><given-names>JR</given-names></name><name><surname>Patrawalla</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Chavda</surname><given-names>KD</given-names></name><name><surname>Mathema</surname><given-names>B</given-names></name><name><surname>Vinnard</surname><given-names>C</given-names></name><name><surname>Dever</surname><given-names>LL</given-names></name><name><surname>Kreiswirth</surname><given-names>BN</given-names></name></person-group><article-title>Colistin- and carbapenem-resistant <italic>Escherichia coli</italic> harboring mcr-1 and blaNDM-5, causing a complicated urinary tract infection in a patient from the United States</article-title><source>MBio</source><year>2016</year><pub-id pub-id-type="doi">10.1128/mBio.01191-16</pub-id><?supplied-pmid 27578755?><pub-id pub-id-type="pmid">27578755</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutgring</surname><given-names>JD</given-names></name><name><surname>Machado</surname><given-names>MJ</given-names></name><name><surname>Benahmed</surname><given-names>FH</given-names></name><name><surname>Conville</surname><given-names>P</given-names></name><name><surname>Shawar</surname><given-names>RM</given-names></name><name><surname>Patel</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>AC</given-names></name></person-group><article-title>FDA-CDC Antimicrobial Resistance Isolate Bank: a publicly available resource to support research, development, and regulatory requirements</article-title><source>J Clin Microbiol</source><year>2018</year><pub-id pub-id-type="doi">10.1128/JCM.01415-17</pub-id><?supplied-pmid 29386262?><pub-id pub-id-type="pmid">29386262</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wikler</surname><given-names>MA</given-names></name></person-group><article-title>Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard</article-title><source>CLSI</source><year>2015</year><volume>26</volume><fpage>M7</fpage><lpage>A7</lpage></element-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="other">Parthasarathy A. 2019. Scanning electron microscopy (SEM) for microbes- a simple and inexpensive method for sample preparation. 10.13140/RG.2.2.26222.05449</mixed-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zipperer</surname><given-names>A</given-names></name><name><surname>Konnerth</surname><given-names>MC</given-names></name><name><surname>Laux</surname><given-names>C</given-names></name><name><surname>Berscheid</surname><given-names>A</given-names></name><name><surname>Janek</surname><given-names>D</given-names></name><name><surname>Weidenmaier</surname><given-names>C</given-names></name><name><surname>Burian</surname><given-names>M</given-names></name><name><surname>Schilling</surname><given-names>NA</given-names></name><name><surname>Slavetinsky</surname><given-names>C</given-names></name><name><surname>Marschal</surname><given-names>M</given-names></name><name><surname>Willmann</surname><given-names>M</given-names></name><name><surname>Kalbacher</surname><given-names>H</given-names></name><name><surname>Schittek</surname><given-names>B</given-names></name><name><surname>Br&#x000f6;tz-Oesterhelt</surname><given-names>H</given-names></name><name><surname>Grond</surname><given-names>S</given-names></name><name><surname>Peschel</surname><given-names>A</given-names></name><name><surname>Krismer</surname><given-names>B</given-names></name></person-group><article-title>Human commensals producing a novel antibiotic impair pathogen colonization</article-title><source>Nature</source><year>2016</year><volume>535</volume><fpage>511</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/nature18634</pub-id><pub-id pub-id-type="pmid">27466123</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thaker</surname><given-names>MN</given-names></name><name><surname>Waglechner</surname><given-names>N</given-names></name><name><surname>Wright</surname><given-names>GD</given-names></name></person-group><article-title>Antibiotic resistance-mediated isolation of scaffold-specific natural product producers</article-title><source>Nat Protoc</source><year>2014</year><volume>9</volume><fpage>1469</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1038/nprot.2014.093</pub-id><pub-id pub-id-type="pmid">24874813</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shanthakumar</surname><given-names>SP</given-names></name><name><surname>Duraisamy</surname><given-names>P</given-names></name><name><surname>Vishwanath</surname><given-names>G</given-names></name><name><surname>Selvanesan</surname><given-names>BC</given-names></name><name><surname>Ramaraj</surname><given-names>V</given-names></name><name><surname>Vasantharaj</surname><given-names>DB</given-names></name></person-group><article-title>Broad spectrum antimicrobial compounds from the bacterium <italic>Exiguobacterium mexicanum</italic> MSSRFS9</article-title><source>Microbiol Res</source><year>2015</year><volume>178</volume><fpage>59</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.micres.2015.06.007</pub-id><pub-id pub-id-type="pmid">26302848</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinet</surname><given-names>L</given-names></name><name><surname>Na&#x000f4;m&#x000e9;</surname><given-names>A</given-names></name><name><surname>Deflandre</surname><given-names>B</given-names></name><name><surname>Maciejewska</surname><given-names>M</given-names></name><name><surname>Tellatin</surname><given-names>D</given-names></name><name><surname>Tenconi</surname><given-names>E</given-names></name><name><surname>Smargiasso</surname><given-names>N</given-names></name><name><surname>de Pauw</surname><given-names>E</given-names></name><name><surname>van Wezel</surname><given-names>GP</given-names></name><name><surname>Rigali</surname><given-names>S</given-names></name></person-group><article-title>A single biosynthetic gene cluster is responsible for the production of bagremycin antibiotics and ferroverdin iron chelators</article-title><source>mBio</source><year>2019</year><pub-id pub-id-type="doi">10.1128/mBio.01230-19</pub-id><?supplied-pmid 31409675?><pub-id pub-id-type="pmid">31409675</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>PN</given-names></name><name><surname>Yen</surname><given-names>MR</given-names></name><name><surname>Chiang</surname><given-names>CY</given-names></name><name><surname>Lin</surname><given-names>HC</given-names></name><name><surname>Chen</surname><given-names>PY</given-names></name></person-group><article-title>Detecting and prioritizing biosynthetic gene clusters for bioactive compounds in bacteria and fungi</article-title><source>Appl Microbiol Biotechnol</source><year>2019</year><volume>103</volume><fpage>3277</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1007/s00253-019-09708-z</pub-id><pub-id pub-id-type="pmid">30859257</pub-id></element-citation></ref></ref-list></back></article>